Zhang, Xian
Yang, Junfang
Li, Jingjing
Li, Wenqian
Song, Dan
Lu, Xin-an
Wu, Fei
Li, Jianqiang
Chen, Dandan
Li, Xiangqun
Xu, Zhongwei
Liu, Shuqiang
Li, Ziyu
Ying, Kui
Lu, Peihua https://orcid.org/0000-0002-6331-7369
Article History
Received: 27 January 2021
Accepted: 3 July 2021
First Online: 7 August 2021
Declarations
:
: Xin-an Lu and Fei Wu are employees of Immunochina Pharmaceuticals Co., Ltd. Jianqiang Li and Dandan Chen are employees of Hebei Senlang Biotechnology, Xiangqun Li are employees of Doing Biomedical Co., Ltd, Zhongwei Xu are employees of Bioceltech Therapeutics Co., Ltd, and Shuqiang Liu are employees of Tianjin Mycure Medical Technology Co., Ltd. This study was partly sponsored by Immunochina Pharmaceuticals Co., Ltd. Hebei Senlang Biotechnology, Doing Biomedical Co., Ltd, Bioceltech Therapeutics Co., Ltd, and Tianjin Mycure Medical Technology Co., Ltd. The other authors have no conflicts of interest to declare.